家庭护理环境中的用药错误:Ramathibodi中毒中心13年回顾性队列研究
该研究回顾了2011–2023年Ramathibodi中毒中心925例在医疗设施外发生用药错误的患者,儿童(<15岁)占68.1%,几乎均<10岁。用错药物占72.4%,用错剂量占27.4%,常见涉及外用皮肤科/抗菌剂、镇痛药和草药/传统产品。导致伤害的事件常见(Category E 58.6%,Category F 25.8%),但多数仅需支持治疗,无死亡。多因素分析显示基础疾病(aOR 3.10;95%CI 1.70–5.66)和用错药物(aOR 2.51;95%CI 1.67–3.76)与伤害独立相关。
要点
- 家庭用药错误中儿童(<15岁)占68.1%,几乎均<10岁,是主要受影响人群。
- 用错药物占72.4%,用错剂量占27.4%,常见物质包括外用皮肤科/抗菌剂、镇痛药和草药/传统产品。
- 导致伤害的事件常见:Category E占58.6%,Category F占25.8%,但多数仅需支持治疗,无死亡。
- 基础疾病(aOR 3.10;95%CI 1.70–5.66)和用错药物(aOR 2.51;95%CI 1.67–3.76)与伤害独立相关。
- 干预应针对药物识别、照护者教育和安全储存实践,以减少可预防伤害。
适用人群与场景
- 纳入2011–2023年Ramathibodi中毒中心记录的在医疗设施外发生用药错误的患者,共925例;儿童(<15岁)占68.1%,几乎均<10岁。
诊断标准与关键阈值
- 伤害定义为国家用药错误报告与预防协调委员会(NCC MERP)Category ≥ E;Category E占58.6%,Category F占25.8%。
- 原文未提及用药错误的诊断标准细节或启动/停止阈值。
处置流程与药物剂量
- 多数病例仅需支持治疗;原文未提及具体药物剂量、给药途径、频次或目标值。
- 原文未提及针对用药错误的具体处置流程步骤。
红旗征与不能漏的情况
- 用错药物(wrong-drug errors)与伤害独立相关(aOR 2.51;95%CI 1.67–3.76),需警惕。
- 存在基础疾病与伤害独立相关(aOR 3.10;95%CI 1.70–5.66),此类患者发生用药错误后风险更高。
- Category E(58.6%)和Category F(25.8%)事件提示需干预或住院的暂时性伤害常见,不能因临床表现轻微而忽视。
研究设计与关键结果
- 研究类型:回顾性队列研究,单中心(Ramathibodi中毒中心),样本量925例,时间2011–2023年。
- 人群:在医疗设施外发生用药错误的患者,儿童(<15岁)占68.1%,几乎均<10岁。
- 干预与对照:无干预对照,为观察性研究。
- 主要终点:用错药物占72.4%,用错剂量占27.4%;伤害Category E占58.6%,Category F占25.8%;无死亡。
- 关键次要终点:多因素分析显示基础疾病(aOR 3.10;95%CI 1.70–5.66)和用错药物(aOR 2.51;95%CI 1.67–3.76)与伤害独立相关。
- 不良事件:原文未提及除伤害分类外的其他不良事件。
证据类型、等级与局限
- 证据类型:回顾性队列研究(单中心)。
- 证据等级或推荐强度:原文未提及。
- 局限:单中心、回顾性设计;原文未提及其他局限。
对床旁实践的改变
- 在急诊/ICU接诊家庭用药错误患者时,应重点关注儿童(尤其<10岁)和用错药物的情况,因用错药物与伤害独立相关。
- 对有基础疾病的患者发生用药错误后应提高警惕,因其与伤害独立相关(aOR 3.10)。
- 多数病例仅需支持治疗,但Category E/F事件常见,需评估是否需要干预或住院。
- 原文提示干预应针对药物识别、照护者教育和安全储存,但未提供具体实施方案。
指南或共识出处
- 原文未提及指南或共识名称;研究来源为Ramathibodi Poison Center 2011–2023年数据。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Medication errors are a leading cause of preventable harm worldwide, yet evidence has predominantly focused on healthcare settings, with limited data from home care, particularly in Southeast Asia.
METHODS: We conducted a retrospective cohort study using 2011-2023 data from the Ramathibodi Poison Center, including patients with medication errors occurring outside healthcare facilities. Clinical effects, management of medication errors, and outcomes were considered as primary outcomes, while the secondary outcome was factors associated with harm, defined as National Coordinating Council for Medication Error Reporting and Prevention Category ≥ E.
RESULTS: A total of 925 patients were included. Children (<15 years) accounted for 68.1% of cases, with almost all aged under 10 years. Wrong-drug errors predominated (72.4%), followed by wrong-dose errors (27.4%). Commonly implicated substances included topical dermatologic/antiseptic agents, analgesics, and herbal/traditional products. Medication errors resulting in patient harm were frequent (Category E, 58.6%; Category F, 25.8%), although most cases were managed with supportive care, and no fatalities occurred. In multivariable analysis, underlying disease (adjusted odds ratio 3.10; 95% CI 1.70-5.66) and wrong-drug errors (adjusted odds ratio 2.51; 95% CI 1.67-3.76) were independently associated with harm.
DISCUSSION: Home-based medication errors predominantly affected children and were largely driven by caregiver-dependent administration of incorrect medications. The predominance of wrong-drug errors suggests that failures in medication identification and storage, rather than dosing complexity alone, are central mechanisms in this setting. The high proportion of Categories E and F events indicates that these medication errors frequently result in clinically meaningful harm, despite the generally mild clinical presentation. The absence of fatalities might reflect the involvement of commonly available medications and timely access to healthcare services. Factors contributing to harm due to medication errors include the presence of underlying disease and wrong-drug errors.
CONCLUSION: Medication errors in home care settings commonly result in temporary harm requiring intervention or hospitalization. Interventions targeting medication identification, caregiver education, and safe storage practices are essential to reduce preventable harm.
参考来源
- Tansuwannarat P, Wangpipatwong M, Tongpoo A, et al. Medication errors in home care settings: a 13-year retrospective cohort study in the Ramathibodi Poison Center. Clin Toxicol (Phila). 2026. PMID: 42663262. doi:10.1080/15563650.2026.2712465
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。